Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35.
Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35.
复制标题
DOI:
10.1111/bph.15919
复制
发表时间:
2022-10
影响因子:
7.3
通讯作者:
中科院分区:
文献类型:
--
作者:
We discuss the fascinating pharmacology of formylpeptide receptor 2 (FPR2; often referred to as FPR2/ALX since it binds lipoxin A4). Initially identified as a low‐affinity ‘relative’ of FPR1, FPR2 presents complex and diverse biology. For instance, it is activated by several classes of agonists (from peptides to proteins and lipid mediators) and displays diverse expression patterns on myeloid cells as well as epithelial cells and endothelial cells, to name a few. Over the last decade, the pharmacology of FPR2 has progressed from being considered a weak chemotactic receptor to a master‐regulator of the resolution of inflammation, the second phase of the acute inflammatory response. We propose that exploitation of the biology of FPR2 offers innovative ways to rectify chronic inflammatory states and represents a viable avenue to develop novel therapies. Recent elucidation of FPR2 structure will facilitate development of the anti‐inflammatory and pro‐resolving drugs of next decade.
登录
查看更多内容
DOI:
10.1016/0006-291x(90)91143-g
发表时间:
1990-05-16
影响因子:
3.1
作者:
BOULAY, F;TARDIF, M;VIGNAIS, P
通讯作者:
VIGNAIS, P
影响因子:
3.6
作者:
Bae, YS;Park, JC;Ryu, SH
通讯作者:
Ryu, SH
DOI:
10.4049/jimmunol.1003145
发表时间:
2011-04-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Brancaleone V;Dalli J;Bena S;Flower RJ;Cirino G;Perretti M
通讯作者:
Perretti M
影响因子:
2.7
作者:
Burli, Roland W.;Xu, Han;Hungate, Randall
通讯作者:
Hungate, Randall
影响因子:
13.6
作者:
Brennan, Eoin P.;Nolan, Karen A.;Godson, Catherine
通讯作者:
Godson, Catherine